ThePrintPod: US lawsuit settlement puts spotlight back on ranitidine. India still undecided on ‘cancer-risk’ drug
ThePrint

ThePrintPod: US lawsuit settlement puts spotlight back on ranitidine. India still undecided on ‘cancer-risk’ drug

2023-10-13

Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.----more----Read full article here: https://theprint.in/health/us-lawsuit-settlement-puts-spotlight-back-on-ranitidine-india-still-undecided-on-cancer-risk-drug/1801469/

Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free